Search results
Author(s):
Devi Nair
,
Laurence Epstein
,
Robert D Schaller
Added:
6 months ago
In this essential episode of Rhythm Interventions Unplugged, host Dr Devi Nair (St. Bernard's Medical Center, US) sits down with two leading experts in cardiac device management: Dr Larry Epstein and Dr Robert Schaller. Together, they explore a critical challenge facing electrophysiologists today - managing pacemaker and ICD leads in patients requiring tricuspid valve interventions.Dr Epstein and…
View more
Same-day Discharge Following PCI: A Meta-analysis of RCTs
Author(s):
Ngoc Huy Nguyen
,
Thanh Ngoc Le
,
Hoai Thi Thu Nguyen
,
et al
Added:
10 months ago
Systematic Review
Sex Difference in Relative Survival Following PCI
Author(s):
Jin-Ho Choi
,
Jung-Min Choi
,
Ki-Hong Choi
,
et al
Added:
1 year ago
Original Research
Author(s):
Nadira Hamid
,
Rahul P Sharma
Added:
5 months ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and…
View more
Author(s):
David J Cohen
Added:
5 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of…
View more
Author(s):
Dee Dee Wang
Added:
8 months ago
Navigate the complexities of patient-prosthesis mismatch (PPM) in transcatheter aortic valve replacement with Dr Dee Dee Wang, exploring the critical distinctions that will shape 2025 clinical practice.This comprehensive presentation dissects the three distinct types of PPM, moving beyond traditional definitions to examine the real-world challenges facing interventional cardiologists today. Dr…
View more
Author(s):
Added:
9 months ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an…
View more
NY Valves 2025 Late-Breaking Science Collection
Video Series
Author(s):
Thomas Modine
Added:
11 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Atrioventricular (AV) Valves Summit 2024
Video Series